Xeljanz XR 11 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FS8TV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,792
Award facts
- Contract value 100% obligated
- $12,792.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,792.06 to AmerisourceBergen Drug Corp for the supply of XELJANZ XR 11 MG tablets (30-count units). The contract was executed as a firm fixed-price delivery order with an ultimate completion date of January 7, 2026, and carries no set-aside designation, indicating it was awarded through full and open competition. This award was fulfilled from AmerisourceBergen's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999.999 billion through December 2031. The product will be sourced from the awardee's corporate office located in Conshohocken, Pennsylvania.
This delivery order represents a routine pharmaceutical procurement to support military healthcare operations through DLA's established pharmaceutical supply chain. AmerisourceBergen/Cencora serves as a critical vendor for federal medical procurement, leveraging its comprehensive IDC to deliver brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to military treatment facilities and other federal healthcare systems worldwide. The firm fixed-price structure and competitive award methodology demonstrate the company's established capability to efficiently fulfill government pharmaceutical requirements within the DLA's medical supply network.
Quick answers
Who was awarded contract SPE2DR26FS8TV?
SPE2DR26FS8TV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FS8TV worth?
The government has obligated $12,792 on SPE2DR26FS8TV.
Is contract SPE2DR26FS8TV an order under another contract?
Yes. SPE2DR26FS8TV is a delivery order under SPE2DR25D3021, an indefinite delivery contract.
Was contract SPE2DR26FS8TV competed?
The extent of competition for SPE2DR26FS8TV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award